Dynamic Enhancer Methylation--A Previously Unrecognized Switch for Tissue-Type Plasminogen Activator Expression

PLoS One. 2015 Oct 28;10(10):e0141805. doi: 10.1371/journal.pone.0141805. eCollection 2015.

Abstract

Tissue-type plasminogen activator (t-PA), which is synthesized in the endothelial cells lining the blood vessel walls, is a key player in the fibrinolytic system protecting the circulation against occluding thrombus formation. Although classical gene regulation has been quite extensively studied in order to understand the mechanisms behind t-PA regulation, epigenetics, including DNA methylation, still is a largely unexplored field. The aim of this study was to establish the methylation pattern in the t-PA promoter and enhancer in non-cultured compared to cultured human umbilical vein endothelial cells (HUVECs), and to simultaneously examine the level of t-PA gene expression. Bisulphite sequencing was used to evaluate the methylation status, and real-time RT-PCR to determine the gene expression level. While the t-PA promoter was stably unmethylated, we surprisingly observed a rapid reduction in the amount of methylation in the enhancer during cell culturing. This demethylation was in strong negative correlation with a pronounced (by a factor of approximately 25) increase in t-PA gene expression levels. In this study, we show that the methylation level in the t-PA enhancer appears to act as a previously unrecognized switch controlling t-PA expression. Our findings, which suggest that DNA methylation is quite dynamic, have implications also for the interpretation of cell culture experiments in general, as well as in a wider biological context.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • CpG Islands
  • DNA Methylation*
  • Endothelial Cells / metabolism
  • Enhancer Elements, Genetic*
  • Gene Expression Profiling
  • Gene Expression Regulation*
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Promoter Regions, Genetic
  • Tissue Plasminogen Activator / genetics*

Substances

  • Tissue Plasminogen Activator

Grants and funding

Funding provided by Swedish research council: 521-2012-2392 (http://www.vr.se/), SJ; Swedish heart lung foundation: HLR 20110321 (http://www.hjart-lungfonden.se/), SJ; ALF/LUA support at Sahlgrenska University Hospital, SJ; Emelle foundation, MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.